Search results
In this issue of JAMA Dermatology, Patel and colleagues 1 examine mortality after a diagnosis of melanoma in situ. Melanoma in situ is the earliest stage of melanoma (stage 0) and is localized to the outermost layer of skin (epidermis).
- Risk of Mortality After a Diagnosis of Melanoma In Situ
In the present study, we demonstrated that patients who even...
- Risk of Mortality After a Diagnosis of Melanoma In Situ
Patients with melanoma in situ have the same life expectancy as the general population. Further problems are rare from melanoma in situ because the malignant cells within the epidermis have no metastatic potential.
The incidence of melanoma in situ (MIS) is increasing even more rapidly than the incidence of cutaneous malignant melanoma (CMM). Socioeconomic status (SES) is associated with the incidence and outcome of CMM.
In the present study, we demonstrated that patients who even develop a second primary melanoma (in situ or invasive) also had a relative survival greater than 100% at 15 years after receiving their initial diagnosis of MIS.
17 lut 2024 · Objectives: Identify the pathophysiology of malignant melanoma. Interpret diagnostic studies recommended for malignant melanoma. Implement treatment strategies for various stages of nonmetastatic malignant melanoma. Identify the role of the interprofessional team in managing a patient with malignant melanoma.
7 sie 2023 · There are five stages of melanoma. The first stage is called stage 0, or melanoma in situ. The last stage is called stage 4. Survival rates decrease with later stages of melanoma.
24 lut 2021 · In the neck and head region, about 20% of all tumors have a poorer prognosis than CM at other locations [3]. The development of CM is the product of the interaction between host and environmental factors, as with all cancers [4].
